Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxandrolone MCT Oil Solution vs. Tablets in Healthy Adults
NCT03218631Phase 1Completed
- Sponsor
- University of Utah
- Start
- Jul 2017
- Primary completion
- Nov 2017
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of oxandrolone in congenital heart disease (CHD), sponsored by University of Utah. Primary endpoints: Peak Plasma Concentration at 48 hours and Area Under the Plasma Concentration versus Time Curve at 48 hours. Started Jul 2017; status: completed.
02
Drugs
oxandrolone
03
Conditions
congenital heart disease (CHD)
Beyond the preview
Go deeper on NCT03218631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03218631.